| scholarly article | Q13442814 |
| P2093 | author name string | Bauer M | |
| Poisson R | |||
| Fisher E | |||
| Fisher B | |||
| Deutsch M | |||
| Redmond C | |||
| Margolese R | |||
| Montague E | |||
| Wolmark N | |||
| Pilch Y | |||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | breast cancer | Q128581 |
| P304 | page(s) | 665-673 | |
| P577 | publication date | 1985-03-01 | |
| P1433 | published in | The New England Journal of Medicine | Q582728 |
| P1476 | title | Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer | |
| P478 | volume | 312 |
| Q35073692 | "Clinical significance of multifocal and multicentric breast cancers and choice of surgical treatment: a retrospective study on a series of 1158 cases" |
| Q94047202 | A Computational Model of Reasoning from the Clinical Literature |
| Q43819314 | A Profile Of Australian Women Practicing Breast Self-Examination |
| Q35574871 | A Systematic Overview of Radiation Therapy Effects in Breast Cancer |
| Q53048449 | A comparison between the results of simple mastectomy and tumorectomy for breast cancer: the problem of local recurrence. |
| Q43666910 | A comparison of four treatment strategies for ductal carcinoma in situ using decision analysis |
| Q36302522 | A model of knowledge acquisition in early stage breast cancer patients |
| Q30931923 | A note from history: Landmarks in history of cancer, part 7. |
| Q73415849 | A population-based study of the effectiveness of breast conservation for newly diagnosed breast cancer |
| Q52080435 | A prospective study of psychiatric and psychosocial sequelae of bilateral subcutaneous mastectomy. |
| Q37839806 | A review of the oncologic and surgical management of breast cancer in the augmented breast: diagnostic, surgical and surveillance challenges |
| Q33964210 | A shorter fractionation schedule for postlumpectomy breast cancer patients |
| Q36821761 | A survey of general surgeons' attitudes towards breast reconstruction after mastectomy. |
| Q36821207 | A survey of the management of breast cancer in England and Wales |
| Q34698851 | A trial on unruptured intracranial aneurysms (the TEAM trial): results, lessons from a failure and the necessity for clinical care trials |
| Q75448824 | Access to multidisciplinary cancer care: is it linked to the use of breast-conserving surgery with radiation for early-stage breast carcinoma? |
| Q38873686 | Acute and Chronic Complications in Breast Cancer Patients Treated with Intraoperative Radiation Therapy |
| Q38917418 | Acute and Chronic Complications in Patients with Ductal Carcinoma in Situ Treated with Intraoperative Radiation Therapy |
| Q51194625 | Addressing the psychological needs of the conservatively treated breast cancer patient: discussion paper. |
| Q60683126 | Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer |
| Q35952921 | Adjuvant dietary fat intake reduction in postmenopausal breast cancer patient management. The Women's Intervention Nutrition Study (WINS) |
| Q33943639 | Adjuvant radiotherapy after breast conserving surgery for breast cancer. Arbiter |
| Q33645931 | Adjuvant radiotherapy and chemotherapy in breast cancer: 30 year follow-up of survival. |
| Q71954337 | Adjuvant radiotherapy for breast cancer as a risk factor for the development of lung cancer |
| Q33951978 | Adjuvant radiotherapy for breast cancer significantly improves overall survival: the missing link |
| Q34707063 | Adjuvant radiotherapy for early breast cancer: patterns of practice in Ontario. |
| Q33654571 | Adjuvant therapy for resectable breast cancer |
| Q41172478 | Adjuvant therapy in breast cancer. Optimal use in the elderly |
| Q93198496 | Advances in Breast MRI in the Setting of Ductal Carcinoma In Situ |
| Q35490615 | American College of Surgeons Oncology Group (ACOSOG) Z0011: impact on surgeon practice patterns |
| Q71310901 | An analysis of breast cancer in Hungary: experience of the National Institute of Oncology, Budapest |
| Q72869420 | An economic rationale for prostate cancer screening |
| Q39642845 | An exploratory instrumental variable analysis of the outcomes of localized breast cancer treatments in a medicare population |
| Q35605807 | Analysis of incidence and prognostic factors for ipsilateral breast tumour recurrence and its impact on disease-specific survival of women with node-negative breast cancer: a prospective cohort study |
| Q36816634 | Antiseptic toxicity to breast carcinoma in tissue culture: an adjuvant to conservation therapy? |
| Q48015916 | Anxiety, depression and defense mechanisms associated with treatment decisional preferences and quality of life in non-metastatic breast cancer: a 1-year prospective study |
| Q68225749 | Are cosmetic results following conservative surgery and radiation therapy for early breast cancer dependent on technique? |
| Q40405410 | Assessment of quality of life in breast cancer |
| Q96134142 | Association between waiting time for radiotherapy after surgery for early-stage breast cancer and survival outcomes in Ontario: a population-based outcomes study |
| Q30249563 | Association of the Extent of Resection With Survival in Glioblastoma: A Systematic Review and Meta-analysis. |
| Q30578065 | Axillary dissection in breast-conserving surgery for stage I and II breast cancer: a National Cancer Data Base study of patterns of omission and implications for survival |
| Q43789142 | Basingstoke revisited |
| Q36106659 | Benefit of semiannual ipsilateral mammographic surveillance following breast conservation therapy |
| Q73559165 | Benefits of skin-sparing mastectomy: part 1 of the 6-part series on current concepts in breast reconstruction |
| Q35181071 | Biological Markers Predictive of Invasive Recurrence in DCIS. |
| Q44220588 | Biopsy technique has no impact on local recurrence after breast-conserving therapy |
| Q26770246 | Breast Reconstruction after Mastectomy |
| Q40975989 | Breast cancer in elderly women: presentation, survival, and treatment options |
| Q72606307 | Breast cancer in the elderly |
| Q34743679 | Breast cancer outcomes among older women: HMO, fee-for-service, and delivery system comparisons. |
| Q35518860 | Breast cancer recurrence: follow up after treatment for primary breast cancer |
| Q33747672 | Breast cancer screening, diagnosis, and treatment |
| Q40954765 | Breast cancer surgery: a century after Halsted |
| Q42384915 | Breast cancer surgery: who chooses and how? |
| Q40545239 | Breast cancer--trials on conservative surgery |
| Q39654239 | Breast cancer. Advances in management |
| Q36302102 | Breast cancer: from "maximum tolerable" to "minimum effective" treatment |
| Q69820645 | Breast cancer: the new biology in conflict with the old dogma |
| Q41371064 | Breast cancer: the real challenge. |
| Q34176391 | Breast carcinomas of limited extent: frequency, radiologic-pathologic characteristics, and surgical margin requirements |
| Q34700838 | Breast conservation is an effective option in Black, medically indigent patients. |
| Q40087308 | Breast conservation surgery versus total mastectomy among women with localized breast cancer in Soweto, South Africa |
| Q73728113 | Breast conservation surgery, with and without radiotherapy, in women with lymph node-negative breast cancer: a randomised clinical trial in a population with access to public mammography screening |
| Q73440183 | Breast conservation therapy in affiliated county, university, and private hospitals |
| Q83898002 | Breast conservative therapy in east part of China: a retrospective cohort study |
| Q33972804 | Breast conserving therapy |
| Q38214868 | Breast conserving therapy for DCIS--does size matter? |
| Q57217392 | Breast conserving therapy in stage I & II breast cancer in Korea |
| Q50961020 | Breast conserving therapy versus mastectomy for stage I-II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial. |
| Q54652106 | Breast-conservative surgery with and without radiotherapy in patients aged 55-75 years with early-stage breast cancer: a prospective, randomized, multicenter trial analysis after 108 months of median follow-up. |
| Q44517514 | Breast-conserving surgery for breast cancer: Patterns of care in a geographic region and estimation of potential applicability |
| Q69708879 | Breast-conserving surgery with radiation therapy for operable mammary carcinoma: a 25-year experience |
| Q34259422 | Breast-conserving therapy for early-stage breast cancer |
| Q44740436 | Breast-conserving therapy versus modified radical mastectomy in the treatment of early breast cancer in Japan |
| Q43605017 | Breast-conserving treatment or mastectomy in early breast cancer: a clinical decision analysis with special reference to the risk of local recurrence |
| Q69912863 | Cancer and pregnancy |
| Q39521068 | Cancer cure with organ preservation using radiation therapy |
| Q41155657 | Case‐survival rates for infiltrating ductal carcinomas by category of hospital at diagnosis in South Australia |
| Q69966754 | Changes in the surgical management of early breast cancer in England |
| Q33889056 | Changes in the use of radiotherapy in Ontario 1984-1995. |
| Q36080670 | Changes in use of breast-conserving therapy in years 1978-2000 |
| Q36064922 | Changing Beliefs and Practices in Women With Breast Cancer in China |
| Q37656638 | Changing cancer care in the 1990s and the cost |
| Q39395767 | Changing practices in the surgical treatment of breast cancer in Japan: a nationwide survey by the Japanese Breast Cancer Society |
| Q33725005 | Choosing quality of care measures based on the expected impact of improved care on health |
| Q58877891 | Clinical behavior of untreated axillary nodes after local treatment for primary breast cancer |
| Q33898408 | Clinical comparison of four types of skin incisions for skin-sparing mastectomy and immediate breast reconstruction |
| Q51283791 | Clinical significance following breast conservation therapy with or without irradiation in breast cancer patients. |
| Q34069941 | Clinical trials and the acceptance of uncertainty |
| Q35555963 | Clinical trials in the era of personalized oncology |
| Q34248661 | Collaborative Initiatives in the Care of Early Stage Breast Cancer: Reduction in Variation of Breast-Conserving Therapy |
| Q70822180 | Combined modality approach for high-risk breast cancer. The Milan Cancer Institute experience |
| Q34337369 | Commentary--surgical decisions after breast cancer: can patients be too involved in decision making? |
| Q44372288 | Comparison of pain, motion, and edema after modified radical mastectomy vs. local excision with axillary dissection and radiation |
| Q70464836 | Comparison of postoperative wound complications and early cancer recurrence between patients undergoing mastectomy with or without immediate breast reconstruction |
| Q51075355 | Comparison of psychological aspects and patient satisfaction following breast conserving surgery, simple mastectomy and breast reconstruction. |
| Q34539312 | Competing considerations in regional nodal treatment for early breast cancer. |
| Q33554036 | Completion of adjuvant radiation therapy among women with breast cancer |
| Q37797758 | Compliance Differences Between Patients With Breast Cancer in University and County Hospitals |
| Q43435574 | Conservation of the breast using two different radiotherapy techniques: interim report of a clinical trial |
| Q39548577 | Conservation surgery and radiation therapy for the treatment of breast cancer. Hypothetical objections and historical perspective |
| Q40598998 | Conservation surgery for breast cancer: selection criteria and technical considerations |
| Q68459692 | Conservative Treatment of breast Cancer in Italy. A Survey |
| Q74404323 | Conservative surgery and radiation therapy for macroscopically multiple ipsilateral invasive breast cancers |
| Q73879238 | Conservative surgery and radiotherapy for early-stage breast cancer using a lung density correction: the University of Michigan experience |
| Q40759301 | Conservative surgery for the management of invasive and noninvasive carcinoma of the breast: NSABP trials. National Surgical Adjuvant Breast and Bowel Project |
| Q70139471 | Conservative treatment for breast cancer. Complications requiring reconstructive surgery |
| Q47597990 | Conservative treatment of breast cancer in Europe: report of the Groupe Européen de Curiethérapie |
| Q69916057 | Conservative treatment of breast cancer with QU.A.R.T. Technique |
| Q44232198 | Conservative treatment of early breast cancer. Long-term results of 1232 cases treated with quadrantectomy, axillary dissection, and radiotherapy |
| Q39375659 | Conservative treatment of early-stage breast cancer in a medically indigent population |
| Q26744320 | Contralateral prophylactic mastectomy: current perspectives |
| Q40779390 | Controversies in primary breast cancer management |
| Q73223977 | Controversies in the Surgical Management of Operable Breast Cancer |
| Q37360560 | Cosmetic effect in patients with early breast cancer treated with breast conserving therapy (BCT) and with HDR brachytherapy (HDR-BT) "boost". |
| Q72998870 | Cost analysis of breast conservation surgery compared with modified radical mastectomy with and without reconstruction |
| Q42907076 | Curing Operable Stage I Non-Small Cell Lung Cancer With Stereotactic Ablative Body Radiotherapy: The Force Awakens |
| Q50076386 | Current Trends in Postmastectomy Breast Reconstruction. |
| Q40921550 | Current Trends in the Oncologic and Surgical Managements of Breast Cancer in Women with Implants: Incidence, Diagnosis, and Treatment |
| Q57617615 | Current perceptions regarding surgical margin status after breast-conserving therapy: results of a survey |
| Q54574108 | DEAD box 1 (DDX1) expression predicts for local control and overall survival in early stage, node-negative breast cancer. |
| Q33627178 | Declining recurrence among ductal carcinoma in situ patients treated with breast-conserving surgery in the community setting |
| Q48607798 | Declining use of mastectomy for invasive breast cancer in Canada, 1981-2000. |
| Q71816269 | Depressive symptomatology of post-menopausal breast cancer patients: a comparison of women recently treated by mastectomy or by breast-conserving therapy |
| Q40598502 | Determinants and prognoses of locoregional and distant progression in breast cancer |
| Q37368023 | Development of a patient decision aid for choice of surgical treatment for breast cancer |
| Q37270931 | Diagnosis and medical treatment of breast cancer. Cordoba Consensus of 2007. |
| Q46060448 | Differences in breast cancer stage at diagnosis between non-Hispanic white and Hispanic populations, San Diego County 1988-1993. |
| Q36294836 | Directions for a psychology research agenda in cancer |
| Q36461748 | Disparities in the Use of Breast-Conserving Therapy Among Patients With Early-Stage Breast Cancer |
| Q90049544 | Do early HER2-overexpression breast cancer patients benefit from undergoing neoadjuvant trastuzumab and mastectomy? A meta-analysis |
| Q90044249 | Does every woman presenting with malignant calcifications require a post lumpectomy mammogram? |
| Q30463534 | Ductal carcinoma in situ of the breast: a surgical perspective |
| Q41079288 | Ductal carcinoma in situ of the breast: progress and controversy. |
| Q46164882 | Ductal carcinoma in situ: recent history and areas of controversy |
| Q38617593 | Early breast cancer. A review |
| Q38215041 | Early experience with ultrasound features after intrabeam intraoperative radiation for early stage breast cancer |
| Q39588563 | Early-stage breast cancer treatment among medically underserved women diagnosed in a national screening program, 1992-1995. |
| Q42030197 | Editorial Comment on adjuvant radiotherapy study |
| Q57134893 | Effect of Season and Climate on Choice of Therapy for Breast Cancer in Older Women |
| Q44429775 | Electrocautery instruments have been used routinely for the excision of tissue from the urinary bladder, prostate gland, and other sites for many years |
| Q27015651 | Emergence of stereotactic body radiation therapy and its impact on current and future clinical practice |
| Q40488017 | Epirubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cancer chemotherapy |
| Q35352739 | Estimating Decision-Relevant Comparative Effects Using Instrumental Variables |
| Q53676668 | Ethical issues and clinical trials. |
| Q89421311 | Evaluation of a new predictor of heart and left anterior descending artery dose in patients treated with adjuvant radiotherapy to the left breast |
| Q33504879 | Evolution of breast cancer management in Ireland: a decade of change |
| Q34494037 | Evolution of breast cancer management: focus on neoadjuvant chemotherapy |
| Q68242992 | External irradiation prior to conservative surgery for breast cancer treatment |
| Q35004173 | Extreme oncoplasty: breast conservation for patients who need mastectomy |
| Q67914217 | Factors affecting recurrence in lumpectomy without irradiation for breast cancer |
| Q37832770 | Factors affecting surgical margins in nonpalpable breast tumors excised with the radioguided occult lesion localization approach |
| Q71543263 | Factors associated with a positive reexcision after excisional biopsy for invasive breast cancer |
| Q36918148 | Factors associated with the frequency of initial total mastectomy: results of a multi-institutional study |
| Q36235597 | Factors increasing local recurrence in breast-conserving surgery. |
| Q37941762 | Factors influencing cosmetic outcome of conservative surgery and radiotherapy for breast cancer |
| Q40881289 | Factors influencing management of breast cancer in the elderly woman. |
| Q44539298 | Factors influencing surgical and adjuvant therapy in stage I breast cancer: a SEER 18 database analysis |
| Q39817629 | Failure pattern and survival after breast conserving therapy. Long-term results of the Danish Breast Cancer Group (DBCG) 89 TM cohort |
| Q39380339 | False premises and false promises of breast cancer screening |
| Q72111722 | Fat necrosis following breast reduction |
| Q42014707 | Fear of mastectomy: the most common factor responsible for late presentation of carcinoma of the breast in Nigeria |
| Q38029521 | Fear of recurrence and perceived survival benefit are primary motivators for choosing mastectomy over breast-conservation therapy regardless of age. |
| Q69496764 | Fine-needle aspiration of the breast |
| Q69233142 | Five year results of radical mastectomy for breast cancer, by a sternal splitting, intrapleural en bloc resection of the internal mammary lymph nodes |
| Q40958170 | Future prospects in limited surgery for early breast cancer |
| Q34195618 | General surgery: alternatives to total mastectomy for carcinoma of the breast. |
| Q35605765 | Genetic predictors of acute toxicities related to radiation therapy following lumpectomy for breast cancer: a case-series study |
| Q36615279 | Guideline adherence for early breast cancer before and after introduction of the sentinel node biopsy. |
| Q40865994 | Hematopoietic progenitor cell transplantation in breast cancer: current status and future directions |
| Q56928447 | Hereditary breast cancer |
| Q44311722 | Histopathological features of invasion of breast invasive ductal carcinoma and safety of breast-conserving surgery |
| Q71952772 | Histopathological study of local residual carcinoma after simulated lumpectomy |
| Q47354788 | History of surgery for breast cancer: radical to the sublime |
| Q74368938 | Hospital volume differences and five-year survival from breast cancer |
| Q85055732 | How do I deal with the axilla in patients with a positive sentinel lymph node? |
| Q49536482 | How to optimize aesthetic outcomes in implant-based breast reconstruction |
| Q26745834 | Hypofractionated whole breast irradiation: new standard in early breast cancer after breast-conserving surgery |
| Q26775841 | Hypofractionated whole breast radiotherapy: current perspectives |
| Q36500256 | Imaging-assisted large-format breast pathology: program rationale and development in a nonprofit health system in the United States |
| Q37806657 | Impact of Routine Cavity Shave Margins on Breast Cancer Re-excision Rates |
| Q53473190 | Impact of surgery and chemotherapy on the quality of life of younger women with breast carcinoma: a prospective study. |
| Q90650626 | Impact on Health-Related Quality of Life of Parenteral Nutrition for Patients with Advanced Cancer Cachexia: Results from a Randomized Controlled Trial |
| Q51011599 | Implementation of educational video improves patient understanding of basic breast cancer concepts in an undereducated county hospital population. |
| Q52080142 | Improved dose homogeneity to the intact breast using three-dimensional treatment planning: technical considerations. |
| Q77839086 | Incidence of the superficial fascia and its relevance in skin-sparing mastectomy |
| Q57890991 | Increased proliferative activity and p53 expression in normal glandular breast tissue after radiation therapy |
| Q50107957 | Increasing mastectomy rates-the effect of environmental factors on the choice for mastectomy: a comparative analysis between Canada and the United States |
| Q35367255 | Indications for breast conservation in early stage breast cancer |
| Q69521934 | Influence of radiotherapy on the dose of adjuvant chemotherapy in early breast cancer |
| Q78008377 | Innovation in surgery: the rules of evidence |
| Q38788014 | Institutional variation in surgical care for early-stage breast cancer at community hospitals |
| Q36190472 | Institutional variation in the surgical treatment of breast cancer: a study of the NCCN. |
| Q74523082 | Intraoperative radiotherapy given as a boost after breast-conserving surgery in breast cancer patients |
| Q50754518 | Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial. |
| Q38513748 | Ipsilateral breast tumor recurrence after breast-conserving therapy: A comparison of quadrantectomy versus lumpectomy at a single institution |
| Q49885178 | Is Mastectomy Oncologically Safer than Breast-Conserving Treatment in Early Breast Cancer? |
| Q38961720 | Is SLN Biopsy Alone Safe in SLN Positive Breast Cancer Patients? |
| Q49898559 | Is invasion a necessary step for metastases in breast cancer? |
| Q34520296 | Is mastectomy overused? A call for an expanded research agenda |
| Q30789643 | Is primary surgery of breast cancer patients consistent with German guidelines? Twelve-year trend of population-based clinical cancer registry data |
| Q39668860 | Is radiation therapy in conjunction with mastectomy indicated for the treatment of operable breast cancer? |
| Q41507244 | Is surgical management compromised in elderly patients with breast cancer? |
| Q43622614 | Isolated late local recurrences with high mitotic count and early local recurrences following breast-conserving therapy are associated with increased risk on distant metastasis |
| Q59616911 | It is possible to omit postoperative irradiation in a highly selected group of elderly breast cancer patients |
| Q39542095 | Knowledge and preference for breast conservation therapy among women without breast cancer |
| Q26830129 | Landmark trials affecting the surgical management of invasive breast cancer |
| Q24797004 | Letrozole sensitizes breast cancer cells to ionizing radiation |
| Q69916059 | Limited surgical management for primary breast cancer: a commentary on the NSABP reports |
| Q73224130 | Local Recurrence after Conservative Surgery for Breast Cancer |
| Q41121397 | Local recurrences after breast-conserving treatment: an open problem |
| Q73374269 | Local relapse in primary breast cancer patients with unexcised positive surgical margins after lumpectomy, radiotherapy and chemoendocrine therapy |
| Q67908695 | Loco-regional recurrence and survival after wide local excision, radiotherapy and axillary clearance for early breast cancer |
| Q41013242 | Long-range effect of clinical trial interventions on quality of life |
| Q35023352 | Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS. |
| Q52067525 | Long-term psychological sequelae of mastectomy and breast conserving treatment for breast cancer. |
| Q33843871 | Long-term results of wide-field brachytherapy as the sole method of radiation therapy after segmental mastectomy for T(is,1,2) breast cancer |
| Q73916845 | Low body mass index is an independent predictive factor of local recurrence after conservative treatment for breast cancer |
| Q42363787 | Low-Energy Intraoperative Radiation Therapy and Competing Risks of Local Control and Normal Tissue Toxicity |
| Q93641210 | Lumpectomy and axillary dissection for breast cancer: surgical, pathological, and radiation considerations |
| Q73265737 | Lumpectomy margins and much more |
| Q73204584 | Lumpectomy with tamoxifen as primary treatment for elderly women with early-stage breast cancer |
| Q37941749 | Mammography and breast cancer screening |
| Q72871110 | Mammography in the 1990s: a plea for objective doctors and informed patients |
| Q36576082 | Management of breast cancer: what do I tell the patient? |
| Q57522228 | Management of ductal carcinoma in situ of the breast |
| Q68290886 | Management of elderly patients with primary breast cancer |
| Q54295810 | Margins in DCIS: Does Residual Disease Provide an Answer? |
| Q70030371 | Margins of "lumpectomy" for breast cancer |
| Q51252463 | Margins: a status report from the Annual Meeting of the American Society of Breast Surgeons. |
| Q36816393 | Mastectomy and breast reconstruction preserving the nipple |
| Q71997409 | Mastectomy from the perspective of a medical oncologist |
| Q64243602 | Mastectomy or Breast-Conserving Therapy for Early Breast Cancer in Real-Life Clinical Practice: Outcome Comparison of 7565 Cases |
| Q35705554 | Mastectomy or conservation: the patient's choice |
| Q69177380 | Mastectomy or conservation: the patient's choice |
| Q54114461 | Mastectomy versus radiotherapy as treatment for stage I-II breast cancer: a prospective randomized trial at the National Cancer Institute. |
| Q36004719 | Memorial sloan-kettering cancer center: two decades of experience with ductal carcinoma in situ of the breast |
| Q84021542 | Meta-analysis of survival of patients with stage 4 colorectal cancer managed with resection versus chemotherapy alone |
| Q39174782 | Milestone clinical trials of the National Surgical Adjuvant Breast and Bowel Project (NSABP). |
| Q41705329 | Milestones in breast cancer treatment |
| Q34074130 | Minimal access breast surgery |
| Q39841850 | Modern surgical treatment of breast cancer |
| Q67915885 | Morphometric studies in intraductal breast carcinoma using computerized image analysis |
| Q74657306 | Mortality from myocardial infarction following postlumpectomy radiotherapy for breast cancer: a population-based study in Ontario, Canada |
| Q79325899 | Multidisciplinary team meetings: where is the value? |
| Q38000228 | Negotiating criteria and setting limits: the case of AIDS. |
| Q44783344 | New lumps in the breast following conservation treatment for early breast cancer |
| Q35182933 | New trends in breast conservation therapy |
| Q70192356 | Nipple involvement and multicentricity in breast cancer. A study on whole organ sections |
| Q33684737 | Nipple-sparing mastectomies: Clinical outcomes from a single academic institution |
| Q37299353 | Nipple-sparing mastectomy: critical assessment of 51 procedures and implications for selection criteria. |
| Q35232559 | Non-invasive breast carcinoma |
| Q36813893 | Non-tumour morbidity and mortality after modified radical mastectomy. |
| Q53848998 | Nonclinical factors associated with surgery received for treatment of early-stage breast cancer |
| Q39734544 | Nonmastectomy treatment of breast cancer. Current status of excision plus radiation |
| Q89850286 | Omission of postoperative radiation after breast conserving surgery: A progressive paradigm shift towards precision medicine |
| Q38759410 | Oncologic reconstruction: General principles and techniques |
| Q38613228 | Oncological safety and cosmetic outcomes in oncoplastic breast conservation surgery, a review of the best level of evidence literature |
| Q53071358 | Oncological safety of autologous fat grafting after breast conservative treatment: a prospective evaluation. |
| Q33973237 | Oncoplastic volume replacement techniques according to the excised volume and tumor location in small- to moderate-sized breasts |
| Q34248600 | Optimal Management of Primary Breast Cancer |
| Q35681377 | Optimal management of ductal carcinoma in situ of the breast |
| Q87609527 | Optimising Breast Conservation Treatment for Multifocal and Multicentric Breast Cancer: A Worthwhile Endeavour?: Reply |
| Q40578981 | Organ and functional preservation in the management of breast cancer |
| Q28749604 | Outcomes following local therapy for early-stage breast cancer in non-trial populations |
| Q38461072 | Outcomes of breast conserving surgery with immediate vicryl-mesh insertion: is it safe and effective? |
| Q35028203 | Overview: current status of breast conserving therapy in Japan |
| Q44618742 | P-value interpretation and alpha allocation in clinical trials |
| Q34264076 | Partial breast reconstruction using various oncoplastic techniques for centrally located breast cancer. |
| Q69569772 | Partial mastectomy: pathologic findings and prognosis |
| Q81085542 | Pathological complete response to trastuzumab and paclitaxel in a patient with inflammatory local recurrence following breast conserving surgery |
| Q52839777 | Pathological evaluation of the staging axillary lymph nodes for breast cancer: a national survey in the United Kingdom. |
| Q36815850 | Pathological features of invasive breast cancer associated with a high risk of local recurrence after tumour excision and radical radiotherapy |
| Q33921572 | Patient compliance is critical for equivalent clinical outcomes for breast cancer treated by breast-conservation therapy |
| Q36592759 | Paying on the margin for medical care: Evidence from breast cancer treatments. |
| Q36805834 | Pilot survey of opinions on data falsification in clinical trials |
| Q54293759 | Pneumonectomy: risk factor or innocent bystander? |
| Q51251906 | Poor compliance with breast cancer treatment guidelines in men undergoing breast-conserving surgery. |
| Q40675007 | Post-mastectomy breast reconstruction and its subsequent complications: a comparison between obese and non-obese women with breast cancer |
| Q72138200 | Postoperative irradiation following immediate breast reconstruction using a temporary tissue expander |
| Q70232927 | Practice of breast self examination: disease extent at diagnosis and patterns of surgical care. A report from an Italian study. GIVIO (Interdisciplinary Group for Cancer Care Evaluation) |
| Q47395905 | Predictors of breast conservation therapy: size is not all that matters |
| Q45365012 | Predictors of mastectomy in a certified breast center - the surgeon is an independent risk factor |
| Q35843029 | Predictors of nipple-areolar complex involvement by breast carcinoma: histopathologic analysis of 787 consecutive therapeutic mastectomy specimens |
| Q38423600 | Predictors of re-excision in wire-guided wide local excision for early breast cancer: a Western Australian multi-centre experience. |
| Q53880597 | Preliminary results for prone-position breast irradiation. |
| Q71558087 | Preoperative chemotherapy: where do we go from here? |
| Q68290932 | Preoperative planning of breast implants using the Breast Implant Planning Device (BIPD) |
| Q52375011 | Preservation of the nipple-areola complex in skin-sparing mastectomy for early breast cancer. |
| Q48484884 | Preserving life and conserving the breast |
| Q67876430 | Preventing relapses of breast cancer with modified radical mastectomy |
| Q37699067 | Primary small-cell carcinoma of the breast. |
| Q36923983 | Primary treatment for breast cancer |
| Q35805644 | Proceedings of the consensus conference on neoadjuvant chemotherapy in carcinoma of the breast, April 26-28, 2003, Philadelphia, Pennsylvania |
| Q37198977 | Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancer |
| Q59420919 | Prognosis after regional lymph node recurrence in patients with Stage I-II breast carcinoma treated with breast conservation therapy |
| Q32034551 | Prognosis and treatment of patients with breast tumors of one centimeter or less and negative axillary lymph nodes |
| Q72813183 | Prognostic factors for local recurrence in breast conservation therapy: residual cancers after lumpectomy |
| Q69362178 | Prognostic factors in breast cancer |
| Q68290868 | Prognostic implications of age in breast cancer patients treated with tumorectomy and irradiation or with mastectomy |
| Q35722470 | Progress against cancer (1971-2011): how far have we come? |
| Q71726725 | Prospective hospital-based survey of attitudes of Southern women toward surgical treatment of breast cancer |
| Q58870027 | Präoperatives Staging mit der Mamma-MRT: Pro und Kontra |
| Q59660615 | Psychosocial effect of mastectomy versus conservative surgery in patients with early breast cancer |
| Q69762134 | Psychosocial outcomes of breast cancer therapies: lumpectomy versus mastectomy |
| Q40936627 | Psychosocial sequelae of breast cancer and its treatment |
| Q91926008 | Pulmonary Metastasectomy versus Continued Active Monitoring in Colorectal Cancer (PulMiCC): a multicentre randomised clinical trial |
| Q69146712 | Pulmonary changes in breast cancer patients treated by three different radiotherapy techniques |
| Q37214884 | Quality of life after breast cancer surgery with or without reconstruction |
| Q34249655 | Quality of life as an outcome measure in surgical oncology. |
| Q48347856 | Quality of life in Taiwanese breast cancer survivors with breast-conserving therapy |
| Q34953360 | Quality of life in patients undergoing systemic therapy for advanced breast cancer |
| Q51085261 | Quality of life in the first year after breast cancer surgery: rehabilitation needs and patterns of recovery. |
| Q70537188 | Quality of life measurement in breast cancer |
| Q51096264 | Quality of life of early-stage breast cancer patients treated with radical mastectomy or breast-conserving procedures: results of EORTC Trial 10801. The European Organization for Research and Treatment of Cancer (EORTC), Breast Cancer Co-operative G |
| Q31041853 | RETRACTED: Impact of Cooperative Trial and Sociodemographic Variation on Adjuvant Radiation Therapy Usage in Elderly Women (≥70 Years) with Stage I, Estrogen Receptor-Positive Breast Cancer: Analysis of the National Cancer Data Base |
| Q35362844 | Racial differences in cancer of the male breast--15 year experience in the Detroit metropolitan area |
| Q36935356 | Racial disparities and trends in radiation therapy after breast-conserving surgery for early-stage breast cancer in women, 1992 to 2002 |
| Q40796678 | Radiation changes in the breast |
| Q36587890 | Radiation therapy after breast-conserving surgery |
| Q33841154 | Radiation therapy of the older patient |
| Q35202631 | Radical tumor excision and cosmetic balance in the surgical treatment of breast carcinoma: biquadrantectomy |
| Q39772989 | Radiotherapeutic management of early breast cancer |
| Q46467046 | Radiotherapy after conservative surgery for breast cancer: selective use of iridium-192 wire boost to tumour bed in high risk patients |
| Q39738658 | Radiotherapy and breast conservation |
| Q41313373 | Radiotherapy in the aged. |
| Q44369992 | Randomised controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial. Scottish Cancer Trials Breast Group |
| Q35983045 | Randomised trial of chemotherapy versus endocrine therapy in patients presenting with locally advanced breast cancer (a pilot study) |
| Q51069895 | Randomized trial of a patient decision aid for choice of surgical treatment for breast cancer. |
| Q36446803 | Rationale and indications for limited surgery in breast cancer: current data |
| Q35669351 | Realization of a biomechanical model-assisted image guidance system for breast cancer surgery using supine MRI |
| Q73224714 | Recent Progress in Breast Conserving Therapy: From Experiences in Japan |
| Q39017165 | Recruitment in Clinical Trials: The Use of Zelen's Prerandomization in Recent Neurovascular Studies |
| Q37038671 | Recurrence dynamics does not depend on the recurrence site. |
| Q34486386 | Regional Nodal Irradiation in Early-Stage Breast Cancer |
| Q52492644 | Rehabilitation needs and breast cancer: the first month after primary therapy. |
| Q74292851 | Repeat high-dose external beam irradiation for in-breast tumor recurrence after previous lumpectomy and whole breast irradiation |
| Q36796452 | Results of a breast-cancer-surgery trial compared with observational data from routine practice. |
| Q68272775 | Results of salvage surgery for mammary recurrence following breast-conserving therapy |
| Q69567274 | Results of treatment of primary breast carcinoma by radical radiotherapy with artificial pneumothorax |
| Q35687625 | Retrospective comparison of non-skin-sparing mastectomy and skin-sparing mastectomy with immediate breast reconstruction |
| Q36707332 | Review of general surgery 1985. |
| Q40759305 | Risk factors and management of local recurrence following breast conservation surgery |
| Q78222760 | Risk factors for local recurrence after breast-conserving therapy for invasive carcinomas: a case-control study of histological factors and alterations in oncogene expression |
| Q36027739 | Risk of contralateral breast cancer in Denmark 1943-80. |
| Q73580673 | Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: a population-based study |
| Q41118552 | Salvage mastectomy after failed breast-conserving therapy for carcinoma of the breast |
| Q90381992 | Saving the Breast Saves the Lives of Breast Cancer Patients |
| Q93889290 | Scottish randomised controlled trial of conservation therapy for breast cancer |
| Q46647054 | Second conservative treatment for ipsilateral breast cancer recurrence using high-dose rate interstitial brachytherapy: Preliminary clinical results and evaluation of patient satisfaction |
| Q35559004 | Second malignancies in breast cancer patients following radiotherapy: a study in Florence, Italy |
| Q38754862 | Sector resection with and without radiotherapy in early breast cancer. Presentation of two ongoing prospective multicenter studies in Sweden. Uppsala/Orebro Breast Cancer Study Group |
| Q43945387 | Selection of patients for breast conserving surgery. |
| Q34425423 | Sentinel Node Biopsy Alone versus Completion Axillary Node Dissection in Node Positive Breast Cancer: Systematic Review and Meta-Analysis. |
| Q34139672 | Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial |
| Q40546057 | Sequential High-Dose Alkylating Therapy and Stem Cell Support for High-Risk Stage III Breast Cancer |
| Q71910013 | Seven-year follow-up on 334 patients treated by breast conserving surgery and short course radical postoperative radiotherapy: a report of the Yorkshire Breast Cancer Group |
| Q69208360 | Short term morbidity and cosmesis following lumpectomy and radical radiotherapy for operable breast cancer |
| Q35577448 | Size of invasive breast cancer and risk of local recurrence after breast-conservation therapy |
| Q53591779 | Sonographic diagnosis of abscess following breast-conserving surgery with insertion of nonabsorbable mesh. |
| Q33487487 | Standardized and reproducible methodology for the comprehensive and systematic assessment of surgical resection margins during breast-conserving surgery for invasive breast cancer |
| Q35130819 | Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011 |
| Q74312959 | Surgery in the elderly |
| Q89935424 | Surgical Trends in Breast Cancer in Turkey: An Increase in Breast-Conserving Surgery |
| Q33779166 | Surgical considerations for invasive breast cancer |
| Q39448757 | Surgical management of breast cancer in Australian women in 1993: analysis of Medicare statistics |
| Q34033312 | Surgical management of breast cancer in the future |
| Q71569335 | Surgical margins after needle-localization breast biopsy |
| Q73964376 | Surgical procedures and devices should be evaluated in the same way as medical therapy |
| Q51539394 | Surgical treatment of breast cancer among the elderly in the United States |
| Q73602976 | Surgical treatment of early-stage breast cancer in the Department of Defense Healthcare System |
| Q61698722 | Survey of treatment of primary breast cancer in Italy. GIVIO (Interdisciplinary Group for Cancer Care Evaluation) |
| Q30275201 | Survival after Breast-Conserving Surgery with Whole Breast or Partial Breast Irradiation in Women with Early Stage Breast Cancer: A SEER Data-base Analysis |
| Q76383776 | Survival after surgical treatment of breast cancer |
| Q36035767 | Survival and disease-free benefits with mastectomy versus breast conservation therapy for early breast cancer: a meta-analysis |
| Q38178997 | Systemic therapy for micrometastatic breast cancer |
| Q71832448 | T1 breast carcinoma in women 70 years of age and older may not require axillary lymph node dissection |
| Q53478091 | Taking responsibility for cancer treatment. |
| Q50648630 | Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial. |
| Q69915719 | Tamoxifen versus surgery in elderly patients with breast cancer |
| Q46881099 | Tau proteins expressions in advanced breast cancer and its significance in taxane-containing neoadjuvant chemotherapy |
| Q45171114 | Technic of breast-saving surgery |
| Q34708340 | Temporal trends in breast cancer surgery in Ontario: can one randomized trial make a difference? |
| Q79998517 | The "El Alamo" project (1990-1997): two consecutive hospital-based studies of breast cancer outcomes in Spain |
| Q73835630 | The "adolescence" of clinical research: a surgeon's view |
| Q55314140 | The COSMAM TRIAL a prospective cohort study of quality of life and cosmetic outcome in patients undergoing breast conserving surgery. |
| Q34252675 | The Changing Face of Mastectomy (from Mutilation to Aid to Breast Reconstruction). |
| Q42359019 | The Evolution of Clinical Trials in Oncology: Defining Who Benefits from New Drugs Using Innovative Study Designs |
| Q36119749 | The Globalization of Cooperative Groups |
| Q73224028 | The Impacts of Breast Conserving Treatment and Mastectomy on the Quality of Life in Early-stage Breast Cancer Patients |
| Q37422506 | The Skinner Lecture: a cost-benefit analysis of postoperative radiotherapy in the treatment of early breast cancer |
| Q92263164 | The approach to an isolated close anterior margin in breast conserving surgery |
| Q38132244 | The challenges of individualized care for older patients with localized breast cancer |
| Q38049474 | The changing face of mastectomy: an oncologic and cosmetic perspective |
| Q69820650 | The changing role of surgery in the treatment of breast cancer |
| Q38343036 | The combination of radiotherapy and chemotherapy: a review |
| Q68500865 | The conservative management of primary breast cancer |
| Q37706254 | The different outcomes between breast-conserving surgery and mastectomy in triple-negative breast cancer: a population-based study from the SEER 18 database |
| Q37346273 | The effect of margins on the clinical management of ductal carcinoma in situ of the breast |
| Q35992956 | The effect of systemic adjuvant chemotherapy on local breast recurrence in node positive breast cancer patients treated by lumpectomy without radiation |
| Q54120494 | The end of the beginning of our understanding about accelerated partial breast irradiation. |
| Q89580818 | The evolution of mastectomy surgical technique: from mutilation to medicine |
| Q43475349 | The extent and distribution of cancer in breasts with palpable primary tumors |
| Q36973199 | The half century of clinical trials of the National Surgical Adjuvant Breast And Bowel Project |
| Q74567824 | The impact of age on local control in women with pT1 breast cancer treated with conservative surgery and radiation therapy |
| Q73850924 | The impact of dose-specification policies upon nominal radiation dose received by breast tissue in the conservation treatment of breast cancer |
| Q51966698 | The impact of mastectomy, breast-conserving treatment and immediate breast reconstruction on the quality of life of Chinese women. |
| Q95264047 | The impact of radiation on lymphedema: a review of the literature |
| Q36965125 | The impact of surgical and pathological findings on radiotherapy of early breast cancer |
| Q38591049 | The importance of surgical margins in breast cancer |
| Q71627346 | The importance of the resection margin in conservative surgery for breast cancer |
| Q45282020 | The incidence of lung carcinoma after surgery for breast carcinoma with and without postoperative radiotherapy. Results of National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trials B-04 and B-06. |
| Q79776465 | The landmark surgical trials of the National Surgical Adjuvant Breast and Bowel Project |
| Q45156770 | The long-term prognosis of breast cancer. Retrospective study of 973 patients |
| Q41286833 | The patient's appraisal of the cosmetic result of segmental mastectomy in benign and malignant breast disease |
| Q34997676 | The perspectives of Iranian physicians and patients towards patient decision aids: a qualitative study |
| Q35367235 | The polymerase chain reaction: its use in the molecular characterization and diagnosis of cancers |
| Q70285656 | The postirradiated breast |
| Q36816214 | The primary management of breast cancer: is breast conservation feasible for all patients? |
| Q39750167 | The radiation dose-response relationship for control of primary breast cancer |
| Q45192373 | The recruitment of patients to trials in head and neck cancer: a qualitative study of the EaStER trial of treatments for early laryngeal cancer |
| Q69916055 | The revolution in breast cancer surgery: science or anecdotalism? |
| Q61698719 | The role of attitudes, beliefs, and personal characteristics of Italian physicians in the surgical treatment of early breast cancer |
| Q40931753 | The role of bone marrow transplantation in the management of advanced local disease. |
| Q67914974 | The role of magnetic resonance imaging in the assessment of local recurrent breast carcinoma |
| Q41442068 | The role of radiation therapy after local excision of invasive and noninvasive breast cancer. |
| Q34120229 | The role of selective sentinel lymph node dissection in breast cancer |
| Q74559753 | The significance of involved tumour bed biopsy following wide local excision of breast cancer |
| Q69630913 | The significance of regional lymph node dissection in the surgical management of breast cancer |
| Q68242983 | The significance of the pathology margins of the tumor excision on the outcome of patients treated with definitive irradiation for early stage breast cancer |
| Q68500833 | The surgeon and breast cancer 1987 |
| Q24648406 | The treatment of breast cancer: a study in evolution |
| Q71086100 | The validity of hospital administrative data in monitoring variations in breast cancer surgery |
| Q72234106 | Therapy of small breast cancer--four-year results of a prospective non-randomized study. German Breast Cancer Study Group (GBSG) |
| Q40561023 | Three-dimensional conformal breast irradiation in the prone position. |
| Q74379283 | Time trends in the results of breast conservation in 4694 women |
| Q71776522 | Treating early-stage breast cancer: hospital characteristics associated with breast-conserving surgery |
| Q37121284 | Treatment of Early Breast Cancer with Conservation of the Breast a Review |
| Q68468166 | Treatment of breast cancer among elderly women with segmental mastectomy or segmental mastectomy plus plus postoperative radiotherapy |
| Q42363227 | Treatment of breast cancer: what are the trends in 1986? |
| Q62073063 | Treatment of breast carcinoma in patients with clinically negative axillary lymph nodes using radiotherapy versus axillary dissection |
| Q42371764 | Treatment of cancer in the elderly |
| Q52013581 | Treatment of early stage breast cancer: do surgeons and patients agree regarding whether treatment alternatives were discussed? |
| Q50892457 | Treatment of early-stage breast cancer in the elderly: a health-outcome-based approach. |
| Q69585078 | Treatment of primary breast cancer without mastectomy. The Los Angeles community experience and review of the literature |
| Q40651601 | Treatment of the axilla in early breast cancer: past, present and future. |
| Q36854155 | Trends in Local Therapy Utilization and Cost for Early-Stage Breast Cancer in Older Women: Implications for Payment and Policy Reform |
| Q47779752 | Trends in Media Reports of Celebrities' Breast Cancer Treatment Decisions |
| Q50546357 | Trends in breast-conserving surgery in Denmark, 1982-2002. |
| Q73486242 | Trends in primary surgical and radiation therapy for localized breast cancer in the Detroit Metropolitan area 1973–1992 |
| Q37845309 | Trends in the local treatment of breast cancer: should we be worried? |
| Q83349502 | Trends in the use of implantable accelerated partial breast irradiation therapy for early stage breast cancer in the United States |
| Q37599242 | Tumor bed boost in breast cancer: Brachytherapy versus electron beam |
| Q71627350 | Tumour bed biopsy detects the presence of multifocal disease in patients undergoing breast conservation therapy for primary breast carcinoma |
| Q34278056 | Two hundred years of cancer research. |
| Q37634220 | Understanding breast cancer - The long and winding road |
| Q50542704 | Understanding of breast cancer concepts in an undereducated county hospital population |
| Q34412476 | Understanding of regional variation in the use of surgery |
| Q37986554 | United States trends in the surgical treatment of primary breast cancer |
| Q36327291 | Usefulness of Oncoplastic Volume Replacement Techniques after Breast Conserving Surgery in Small to Moderate-sized Breasts |
| Q37046446 | Usefulness of a lateral thoracodorsal flap after breast conserving surgery in laterally located breast cancer. |
| Q34592360 | Using the Zelen design in randomized controlled trials: debates and controversies. |
| Q60369071 | Utility of parametrectomy for early stage cervical cancer treated with radical hysterectomy |
| Q34707830 | Variation in breast cancer surgery in Ontario. |
| Q45729931 | Variations in cancer survival and patterns of care across Europe: roles of wealth and health-care organization |
| Q80383651 | Variations in surgery for early-stage breast cancer: what are we measuring? |
| Q34569935 | Variations in treatment and survival in breast cancer |
| Q78677343 | Video-assisted total glandectomy and immediate reconstruction for breast cancer |
| Q55086184 | What Drives Patient Choice: Preferences for Approaches to Surgical Treatments for Breast Cancer Beyond Traditional Clinical Benchmarks. |
| Q61713808 | What doctors tell patients with breast cancer about diagnosis and treatment: Findings from a study in general hospitals. GIVIO (Interdisciplinary Group for Cancer Care Evaluation) Italy |
| Q34034865 | What drove changes in the use of breast conserving surgery since the early 1980s? The role of the clinical trial, celebrity action and an NIH consensus statement |
| Q43427825 | Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial |
| Q36815774 | Wide excision of primary breast cancer: the incidence of residual carcinoma at the site of excision |
| Q74770124 | Women 35 years of age or younger have higher locoregional relapse rates after undergoing breast conservation therapy |
| Q47609286 | Women's attitudes toward preventive strategies for hereditary breast or ovarian carcinoma differ from one country to another: differences among English, French, and Canadian women |
| Q42383789 | Writing papers and changing minds. |
| Q46496015 | X-ray triggered release of doxorubicin from nanoparticle drug carriers for cancer therapy |
| Q39474680 | Zelen randomization: attitudes of parents participating in a neonatal clinical trial |
| Q69582138 | [Breast saving therapy in the small breast cancer] |
| Q69731970 | [Breast-saving therapy--a safe alternative in primary treatment of breast cancer?] |
| Q58675092 | [Clinical studies in oncology. Relevance, design, ethical considerations] |
| Q73277535 | [Combined breast-preserving surgery, chemotherapy and radiotherapy in the treatment of breast carcinoma. Effect of the interval between surgery and the beginning of radiotherapy] |
| Q73164447 | [Effect of selenium on the side effect profile of adjuvant chemotherapy/radiotherapy in patients with breast carcinoma. Design for a clinical study] |
| Q75300637 | [Epidemiological study of the GEICAM group about breast cancer in Spain (1990-1993): El Alamo project] |
| Q69731952 | [Morphologic criteria in breast-saving surgery] |
| Q77734730 | [Radiation and concomitant chemotherapy after surgery for breast cancer: Arcosein study ] |
| Q77919374 | [Respective roles of radiotherapy and chemotherapy in adjuvant treatment of cancer of the breast: theoretical importance and feasibility of chemoradiotherapy] |
| Q73611573 | [Role of radiotherapy in the management of adenocarcinoma of the breast accessible to conservative surgery] |
| Q79913739 | [Sentinel lymph node biopsy technique in breast cancer surgery in a hospital without a nuclear medical service] |
| Q42383432 | c-erbB-2 oncogene as a prognostic marker in breast cancer |
| Q73496517 | “Best practice” in surgical management of breast cancer |
Search more.